Chapter 1. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET– By Product

6.1. Reagents and Consumables

6.2. Instrument

Chapter 7. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET– By Test Type

7.1. Immunoassay

7.2. Molecular Diagnostics

7.3. Others

Chapter 8. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET– By Application

8.1. Drug-Resistance Testing

8.2. Disease Testing

Chapter 9. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET– By Infection Type

9.1. Surgical Site Infections

9.2. Gastrointestinal Infections

9.3. Urinary Tract Infections (UTI)

9.4. Hospital Acquired Pneumonia

9.5. Bloodstream Infections

9.6. Others

Chapter 10. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET– By End User

10.1 Standalone Laboratories

10.2. Hospital

10.3. Others

Chapter 11. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET– By Region

11.1. North America

11.2. Europe

11.3.The Asia Pacific

11.4.Latin America

11.5. Middle-East and Africa

Chapter 12. HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

12.1. Company 1

12.2. Company 2

12.3. Company 3

12.4. Company 4

12.5. Company 5

12.6. Company 6

12.7. Company 7

12.8. Company 8

12.9. Company 9

12.10. Company 10